APO Research

APO RESEARCH · REPORT

Biomedical High-Entropy Alloys

Selected research

Industry Research

Biomedical High-Entropy Alloys Industry Research Report 2026

Market perspective

The global Biomedical High-Entropy Alloys market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Biomedical High-Entropy Alloys is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Biomedical High-Entropy Alloys is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Biomedical High-Entropy Alloys is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Biomedical High-Entropy Alloys include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Biomedical High-Entropy Alloys market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Biomedical High-Entropy Alloys.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Biomedical High-Entropy Alloys Market by Company

Heeger Materials

Alloyed

Oerlikon

Beijing Yijin New Material Technology Co., Ltd.

Shanghai Truer

Beijing Crigoo Materials Technology Co, Ltd.

Jiangxi Yongtai Powder Metallurgy Co., Ltd.

Beijing Yanbang New Material Technology Co., Ltd.

Beijing High Entropy Alloy New Material Technology Co., Ltd.

Stanford Advanced Materials

Metalysis

ATT Advanced Elemental Materials Co., Ltd.

STARDUST

GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD.

Beijing Ruichi High-tech Co., Ltd.

Biomedical High-Entropy Alloys Segment by Type

Powder

Rod

Plate

Others

Biomedical High-Entropy Alloys Segment by Application

Biomaterials

Medical Devices

Others

Biomedical High-Entropy Alloys Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical High-Entropy Alloys market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical High-Entropy Alloys and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical High-Entropy Alloys.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Biomedical High-Entropy Alloys manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Biomedical High-Entropy Alloys by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Biomedical High-Entropy Alloys in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biomedical High-Entropy Alloys Production by Manufacturers (Tons) & (2021-2026) Table 6. Global Biomedical High-Entropy Alloys Production Market Share by Manufacturers Table 7. Global Biomedical High-Entropy Alloys Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Biomedical High-Entropy Alloys Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Biomedical High-Entropy Alloys Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Biomedical High-Entropy Alloys Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biomedical High-Entropy Alloys Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Biomedical High-Entropy Alloys Manufacturers, Product Type & Application Table 13. Global Biomedical High-Entropy Alloys Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biomedical High-Entropy Alloys by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Heeger Materials Company Information Table 18. Heeger Materials Business Overview Table 19. Heeger Materials Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 20. Heeger Materials Biomedical High-Entropy Alloys Product Portfolio Table 21. Heeger Materials Recent Development Table 22. Alloyed Company Information Table 23. Alloyed Business Overview Table 24. Alloyed Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 25. Alloyed Biomedical High-Entropy Alloys Product Portfolio Table 26. Alloyed Recent Development Table 27. Oerlikon Company Information Table 28. Oerlikon Business Overview Table 29. Oerlikon Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 30. Oerlikon Biomedical High-Entropy Alloys Product Portfolio Table 31. Oerlikon Recent Development Table 32. Beijing Yijin New Material Technology Co., Ltd. Company Information Table 33. Beijing Yijin New Material Technology Co., Ltd. Business Overview Table 34. Beijing Yijin New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 35. Beijing Yijin New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Product Portfolio Table 36. Beijing Yijin New Material Technology Co., Ltd. Recent Development Table 37. Shanghai Truer Company Information Table 38. Shanghai Truer Business Overview Table 39. Shanghai Truer Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 40. Shanghai Truer Biomedical High-Entropy Alloys Product Portfolio Table 41. Shanghai Truer Recent Development Table 42. Beijing Crigoo Materials Technology Co, Ltd. Company Information Table 43. Beijing Crigoo Materials Technology Co, Ltd. Business Overview Table 44. Beijing Crigoo Materials Technology Co, Ltd. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Beijing Crigoo Materials Technology Co, Ltd. Biomedical High-Entropy Alloys Product Portfolio Table 46. Beijing Crigoo Materials Technology Co, Ltd. Recent Development Table 47. Jiangxi Yongtai Powder Metallurgy Co., Ltd. Company Information Table 48. Jiangxi Yongtai Powder Metallurgy Co., Ltd. Business Overview Table 49. Jiangxi Yongtai Powder Metallurgy Co., Ltd. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. Jiangxi Yongtai Powder Metallurgy Co., Ltd. Biomedical High-Entropy Alloys Product Portfolio Table 51. Jiangxi Yongtai Powder Metallurgy Co., Ltd. Recent Development Table 52. Beijing Yanbang New Material Technology Co., Ltd. Company Information Table 53. Beijing Yanbang New Material Technology Co., Ltd. Business Overview Table 54. Beijing Yanbang New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Beijing Yanbang New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Product Portfolio Table 56. Beijing Yanbang New Material Technology Co., Ltd. Recent Development Table 57. Beijing High Entropy Alloy New Material Technology Co., Ltd. Company Information Table 58. Beijing High Entropy Alloy New Material Technology Co., Ltd. Business Overview Table 59. Beijing High Entropy Alloy New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Beijing High Entropy Alloy New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Product Portfolio Table 61. Beijing High Entropy Alloy New Material Technology Co., Ltd. Recent Development Table 62. Stanford Advanced Materials Company Information Table 63. Stanford Advanced Materials Business Overview Table 64. Stanford Advanced Materials Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Stanford Advanced Materials Biomedical High-Entropy Alloys Product Portfolio Table 66. Stanford Advanced Materials Recent Development Table 67. Metalysis Company Information Table 68. Metalysis Business Overview Table 69. Metalysis Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Metalysis Biomedical High-Entropy Alloys Product Portfolio Table 71. Metalysis Recent Development Table 72. ATT Advanced Elemental Materials Co., Ltd. Company Information Table 73. ATT Advanced Elemental Materials Co., Ltd. Business Overview Table 74. ATT Advanced Elemental Materials Co., Ltd. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. ATT Advanced Elemental Materials Co., Ltd. Biomedical High-Entropy Alloys Product Portfolio Table 76. ATT Advanced Elemental Materials Co., Ltd. Recent Development Table 77. STARDUST Company Information Table 78. STARDUST Business Overview Table 79. STARDUST Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. STARDUST Biomedical High-Entropy Alloys Product Portfolio Table 81. STARDUST Recent Development Table 82. GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Company Information Table 83. GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Business Overview Table 84. GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Biomedical High-Entropy Alloys Product Portfolio Table 86. GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Recent Development Table 87. Beijing Ruichi High-tech Co., Ltd. Company Information Table 88. Beijing Ruichi High-tech Co., Ltd. Business Overview Table 89. Beijing Ruichi High-tech Co., Ltd. Biomedical High-Entropy Alloys Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Beijing Ruichi High-tech Co., Ltd. Biomedical High-Entropy Alloys Product Portfolio Table 91. Beijing Ruichi High-tech Co., Ltd. Recent Development Table 92. Global Biomedical High-Entropy Alloys Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 93. Global Biomedical High-Entropy Alloys Production by Region (2021-2026) & (Tons) Table 94. Global Biomedical High-Entropy Alloys Production Market Share by Region (2021-2026) Table 95. Global Biomedical High-Entropy Alloys Production Forecast by Region (2027-2032) & (Tons) Table 96. Global Biomedical High-Entropy Alloys Production Market Share Forecast by Region (2027-2032) Table 97. Global Biomedical High-Entropy Alloys Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Global Biomedical High-Entropy Alloys Production Value by Region (2021-2026) & (US$ Million) Table 99. Global Biomedical High-Entropy Alloys Production Value Market Share by Region (2021-2026) Table 100. Global Biomedical High-Entropy Alloys Production Value Forecast by Region (2027-2032) & (US$ Million) Table 101. Global Biomedical High-Entropy Alloys Market Average Price (US$/Ton) by Region (2021-2026) Table 102. Global Biomedical High-Entropy Alloys Market Average Price (US$/Ton) by Region (2027-2032) Table 103. Global Biomedical High-Entropy Alloys Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 104. Global Biomedical High-Entropy Alloys Consumption by Region (2021-2026) & (Tons) Table 105. Global Biomedical High-Entropy Alloys Consumption Market Share by Region (2021-2026) Table 106. Global Biomedical High-Entropy Alloys Forecasted Consumption by Region (2027-2032) & (Tons) Table 107. Global Biomedical High-Entropy Alloys Forecasted Consumption Market Share by Region (2027-2032) Table 108. North America Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 109. North America Biomedical High-Entropy Alloys Consumption by Country (2021-2026) & (Tons) Table 110. North America Biomedical High-Entropy Alloys Consumption by Country (2027-2032) & (Tons) Table 111. Europe Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 112. Europe Biomedical High-Entropy Alloys Consumption by Country (2021-2026) & (Tons) Table 113. Europe Biomedical High-Entropy Alloys Consumption by Country (2027-2032) & (Tons) Table 114. Asia Pacific Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 115. Asia Pacific Biomedical High-Entropy Alloys Consumption by Country (2021-2026) & (Tons) Table 116. Asia Pacific Biomedical High-Entropy Alloys Consumption by Country (2027-2032) & (Tons) Table 117. South America, Middle East & Africa Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 118. South America, Middle East & Africa Biomedical High-Entropy Alloys Consumption by Country (2021-2026) & (Tons) Table 119. South America, Middle East & Africa Biomedical High-Entropy Alloys Consumption by Country (2027-2032) & (Tons) Table 120. Global Biomedical High-Entropy Alloys Production by Type (2021-2026) & (Tons) Table 121. Global Biomedical High-Entropy Alloys Production by Type (2027-2032) & (Tons) Table 122. Global Biomedical High-Entropy Alloys Production Market Share by Type (2021-2026) Table 123. Global Biomedical High-Entropy Alloys Production Market Share by Type (2027-2032) Table 124. Global Biomedical High-Entropy Alloys Production Value by Type (2021-2026) & (US$ Million) Table 125. Global Biomedical High-Entropy Alloys Production Value by Type (2027-2032) & (US$ Million) Table 126. Global Biomedical High-Entropy Alloys Production Value Market Share by Type (2021-2026) Table 127. Global Biomedical High-Entropy Alloys Production Value Market Share by Type (2027-2032) Table 128. Global Biomedical High-Entropy Alloys Price by Type (2021-2026) & (US$/Ton) Table 129. Global Biomedical High-Entropy Alloys Price by Type (2027-2032) & (US$/Ton) Table 130. Global Biomedical High-Entropy Alloys Production by Application (2021-2026) & (Tons) Table 131. Global Biomedical High-Entropy Alloys Production by Application (2027-2032) & (Tons) Table 132. Global Biomedical High-Entropy Alloys Production Market Share by Application (2021-2026) Table 133. Global Biomedical High-Entropy Alloys Production Market Share by Application (2027-2032) Table 134. Global Biomedical High-Entropy Alloys Production Value by Application (2021-2026) & (US$ Million) Table 135. Global Biomedical High-Entropy Alloys Production Value by Application (2027-2032) & (US$ Million) Table 136. Global Biomedical High-Entropy Alloys Production Value Market Share by Application (2021-2026) Table 137. Global Biomedical High-Entropy Alloys Production Value Market Share by Application (2027-2032) Table 138. Global Biomedical High-Entropy Alloys Price by Application (2021-2026) & (US$/Ton) Table 139. Global Biomedical High-Entropy Alloys Price by Application (2027-2032) & (US$/Ton) Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Biomedical High-Entropy Alloys Distributors List Table 143. Biomedical High-Entropy Alloys Customers List Table 144. Biomedical High-Entropy Alloys Industry Trends Table 145. Biomedical High-Entropy Alloys Industry Drivers Table 146. Biomedical High-Entropy Alloys Industry Restraints Table 147. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Biomedical High-Entropy Alloys Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Powder Product Image Figure 7. Rod Product Image Figure 8. Plate Product Image Figure 9. Others Product Image Figure 10. Biomaterials Product Image Figure 11. Medical Devices Product Image Figure 12. Others Product Image Figure 13. Global Biomedical High-Entropy Alloys Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Biomedical High-Entropy Alloys Production Value (2021-2032) & (US$ Million) Figure 15. Global Biomedical High-Entropy Alloys Production Capacity (2021-2032) & (Tons) Figure 16. Global Biomedical High-Entropy Alloys Production (2021-2032) & (Tons) Figure 17. Global Biomedical High-Entropy Alloys Average Price (US$/Ton) & (2021-2032) Figure 18. Global Biomedical High-Entropy Alloys Key Manufacturers, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Biomedical High-Entropy Alloys Players Market Share by Production Value in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Biomedical High-Entropy Alloys Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 22. Global Biomedical High-Entropy Alloys Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. Global Biomedical High-Entropy Alloys Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Biomedical High-Entropy Alloys Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Biomedical High-Entropy Alloys Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Europe Biomedical High-Entropy Alloys Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. China Biomedical High-Entropy Alloys Production Value (US$ Million) Growth Rate (2021-2032) Figure 28. Japan Biomedical High-Entropy Alloys Production Value (US$ Million) Growth Rate (2021-2032) Figure 29. Global Biomedical High-Entropy Alloys Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Biomedical High-Entropy Alloys Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 32. North America Biomedical High-Entropy Alloys Consumption Market Share by Country (2021-2032) Figure 33. United States Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 34. United States Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 35. Canada Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 36. Mexico Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 37. Europe Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. Europe Biomedical High-Entropy Alloys Consumption Market Share by Country (2021-2032) Figure 39. Germany Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. France Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. U.K. Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Italy Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Russia Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. Spain Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Netherlands Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Switzerland Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Sweden Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Poland Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Asia Pacific Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Asia Pacific Biomedical High-Entropy Alloys Consumption Market Share by Country (2021-2032) Figure 51. China Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. Japan Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. South Korea Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. India Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Australia Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. Taiwan Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. Southeast Asia Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. South America, Middle East & Africa Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. South America, Middle East & Africa Biomedical High-Entropy Alloys Consumption Market Share by Country (2021-2032) Figure 60. Brazil Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Argentina Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Chile Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Turkey Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. GCC Countries Biomedical High-Entropy Alloys Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. Global Biomedical High-Entropy Alloys Production Market Share by Type (2021-2032) Figure 66. Global Biomedical High-Entropy Alloys Production Value Market Share by Type (2021-2032) Figure 67. Global Biomedical High-Entropy Alloys Price (US$/Ton) by Type (2021-2032) Figure 68. Global Biomedical High-Entropy Alloys Production Market Share by Application (2021-2032) Figure 69. Global Biomedical High-Entropy Alloys Production Value Market Share by Application (2021-2032) Figure 70. Global Biomedical High-Entropy Alloys Price (US$/Ton) by Application (2021-2032) Figure 71. Biomedical High-Entropy Alloys Value Chain Figure 72. Biomedical High-Entropy Alloys Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Biomedical High-Entropy Alloys Industry Opportunities and Challenges

Scope & coverage.

Types
  • Powder
  • Rod
  • Plate
  • Others
Applications
  • Biomaterials
  • Medical Devices
  • Others
Companies covered
  • Heeger Materials
  • Alloyed
  • Oerlikon
  • Beijing Yijin New Material Technology Co., Ltd.
  • Shanghai Truer
  • Beijing Crigoo Materials Technology Co, Ltd.
  • Jiangxi Yongtai Powder Metallurgy Co., Ltd.
  • Beijing Yanbang New Material Technology Co., Ltd.
  • Beijing High Entropy Alloy New Material Technology Co., Ltd.
  • Stanford Advanced Materials
  • Metalysis
  • ATT Advanced Elemental Materials Co., Ltd.
  • STARDUST
  • GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD.
  • Beijing Ruichi High-tech Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Biomedical High-Entropy Alloys by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Powder
  5. 2.2.3 Rod
  6. 2.2.4 Plate
  7. 2.2.5 Others
  8. 2.3 Biomedical High-Entropy Alloys by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  10. 2.3.2 Biomaterials
  11. 2.3.3 Medical Devices
  12. 2.3.4 Others
  13. 2.4 Global Market Growth Prospects
  14. 2.4.1 Global Biomedical High-Entropy Alloys Production Value Estimates and Forecasts (2021-2032)
  15. 2.4.2 Global Biomedical High-Entropy Alloys Production Capacity Estimates and Forecasts (2021-2032)
  16. 2.4.3 Global Biomedical High-Entropy Alloys Production Estimates and Forecasts (2021-2032)
  17. 2.4.4 Global Biomedical High-Entropy Alloys Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Biomedical High-Entropy Alloys Production by Manufacturers (2021-2026)
  2. 3.2 Global Biomedical High-Entropy Alloys Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Biomedical High-Entropy Alloys Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Biomedical High-Entropy Alloys Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biomedical High-Entropy Alloys Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Biomedical High-Entropy Alloys Manufacturers, Product Type & Application
  7. 3.7 Global Biomedical High-Entropy Alloys Manufacturers Established Date
  8. 3.8 Global Biomedical High-Entropy Alloys Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Heeger Materials
  2. 4.1.1 Heeger Materials Biomedical High-Entropy Alloys Company Information
  3. 4.1.2 Heeger Materials Biomedical High-Entropy Alloys Business Overview
  4. 4.1.3 Heeger Materials Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Heeger Materials Product Portfolio
  6. 4.1.5 Heeger Materials Recent Developments
  7. 4.2 Alloyed
  8. 4.2.1 Alloyed Biomedical High-Entropy Alloys Company Information
  9. 4.2.2 Alloyed Biomedical High-Entropy Alloys Business Overview
  10. 4.2.3 Alloyed Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Alloyed Product Portfolio
  12. 4.2.5 Alloyed Recent Developments
  13. 4.3 Oerlikon
  14. 4.3.1 Oerlikon Biomedical High-Entropy Alloys Company Information
  15. 4.3.2 Oerlikon Biomedical High-Entropy Alloys Business Overview
  16. 4.3.3 Oerlikon Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Oerlikon Product Portfolio
  18. 4.3.5 Oerlikon Recent Developments
  19. 4.4 Beijing Yijin New Material Technology Co., Ltd.
  20. 4.4.1 Beijing Yijin New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Company Information
  21. 4.4.2 Beijing Yijin New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Business Overview
  22. 4.4.3 Beijing Yijin New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Beijing Yijin New Material Technology Co., Ltd. Product Portfolio
  24. 4.4.5 Beijing Yijin New Material Technology Co., Ltd. Recent Developments
  25. 4.5 Shanghai Truer
  26. 4.5.1 Shanghai Truer Biomedical High-Entropy Alloys Company Information
  27. 4.5.2 Shanghai Truer Biomedical High-Entropy Alloys Business Overview
  28. 4.5.3 Shanghai Truer Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Shanghai Truer Product Portfolio
  30. 4.5.5 Shanghai Truer Recent Developments
  31. 4.6 Beijing Crigoo Materials Technology Co, Ltd.
  32. 4.6.1 Beijing Crigoo Materials Technology Co, Ltd. Biomedical High-Entropy Alloys Company Information
  33. 4.6.2 Beijing Crigoo Materials Technology Co, Ltd. Biomedical High-Entropy Alloys Business Overview
  34. 4.6.3 Beijing Crigoo Materials Technology Co, Ltd. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Beijing Crigoo Materials Technology Co, Ltd. Product Portfolio
  36. 4.6.5 Beijing Crigoo Materials Technology Co, Ltd. Recent Developments
  37. 4.7 Jiangxi Yongtai Powder Metallurgy Co., Ltd.
  38. 4.7.1 Jiangxi Yongtai Powder Metallurgy Co., Ltd. Biomedical High-Entropy Alloys Company Information
  39. 4.7.2 Jiangxi Yongtai Powder Metallurgy Co., Ltd. Biomedical High-Entropy Alloys Business Overview
  40. 4.7.3 Jiangxi Yongtai Powder Metallurgy Co., Ltd. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Jiangxi Yongtai Powder Metallurgy Co., Ltd. Product Portfolio
  42. 4.7.5 Jiangxi Yongtai Powder Metallurgy Co., Ltd. Recent Developments
  43. 4.8 Beijing Yanbang New Material Technology Co., Ltd.
  44. 4.8.1 Beijing Yanbang New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Company Information
  45. 4.8.2 Beijing Yanbang New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Business Overview
  46. 4.8.3 Beijing Yanbang New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Beijing Yanbang New Material Technology Co., Ltd. Product Portfolio
  48. 4.8.5 Beijing Yanbang New Material Technology Co., Ltd. Recent Developments
  49. 4.9 Beijing High Entropy Alloy New Material Technology Co., Ltd.
  50. 4.9.1 Beijing High Entropy Alloy New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Company Information
  51. 4.9.2 Beijing High Entropy Alloy New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Business Overview
  52. 4.9.3 Beijing High Entropy Alloy New Material Technology Co., Ltd. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Beijing High Entropy Alloy New Material Technology Co., Ltd. Product Portfolio
  54. 4.9.5 Beijing High Entropy Alloy New Material Technology Co., Ltd. Recent Developments
  55. 4.10 Stanford Advanced Materials
  56. 4.10.1 Stanford Advanced Materials Biomedical High-Entropy Alloys Company Information
  57. 4.10.2 Stanford Advanced Materials Biomedical High-Entropy Alloys Business Overview
  58. 4.10.3 Stanford Advanced Materials Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Stanford Advanced Materials Product Portfolio
  60. 4.10.5 Stanford Advanced Materials Recent Developments
  61. 4.11 Metalysis
  62. 4.11.1 Metalysis Biomedical High-Entropy Alloys Company Information
  63. 4.11.2 Metalysis Biomedical High-Entropy Alloys Business Overview
  64. 4.11.3 Metalysis Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Metalysis Product Portfolio
  66. 4.11.5 Metalysis Recent Developments
  67. 4.12 ATT Advanced Elemental Materials Co., Ltd.
  68. 4.12.1 ATT Advanced Elemental Materials Co., Ltd. Biomedical High-Entropy Alloys Company Information
  69. 4.12.2 ATT Advanced Elemental Materials Co., Ltd. Biomedical High-Entropy Alloys Business Overview
  70. 4.12.3 ATT Advanced Elemental Materials Co., Ltd. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 ATT Advanced Elemental Materials Co., Ltd. Product Portfolio
  72. 4.12.5 ATT Advanced Elemental Materials Co., Ltd. Recent Developments
  73. 4.13 STARDUST
  74. 4.13.1 STARDUST Biomedical High-Entropy Alloys Company Information
  75. 4.13.2 STARDUST Biomedical High-Entropy Alloys Business Overview
  76. 4.13.3 STARDUST Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 STARDUST Product Portfolio
  78. 4.13.5 STARDUST Recent Developments
  79. 4.14 GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD.
  80. 4.14.1 GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Biomedical High-Entropy Alloys Company Information
  81. 4.14.2 GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Biomedical High-Entropy Alloys Business Overview
  82. 4.14.3 GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  83. 4.14.4 GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Product Portfolio
  84. 4.14.5 GREES (BEIJING) NEW MATERIAL TECHNOLOGY CO., LTD. Recent Developments
  85. 4.15 Beijing Ruichi High-tech Co., Ltd.
  86. 4.15.1 Beijing Ruichi High-tech Co., Ltd. Biomedical High-Entropy Alloys Company Information
  87. 4.15.2 Beijing Ruichi High-tech Co., Ltd. Biomedical High-Entropy Alloys Business Overview
  88. 4.15.3 Beijing Ruichi High-tech Co., Ltd. Biomedical High-Entropy Alloys Production Capacity, Value and Gross Margin (2021-2026)
  89. 4.15.4 Beijing Ruichi High-tech Co., Ltd. Product Portfolio
  90. 4.15.5 Beijing Ruichi High-tech Co., Ltd. Recent Developments
5 Global Biomedical High-Entropy Alloys Production by Region
  1. 5.1 Global Biomedical High-Entropy Alloys Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Biomedical High-Entropy Alloys Production by Region: 2021-2032
  3. 5.2.1 Global Biomedical High-Entropy Alloys Production by Region: 2021-2026
  4. 5.2.2 Global Biomedical High-Entropy Alloys Production Forecast by Region (2027-2032)
  5. 5.3 Global Biomedical High-Entropy Alloys Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Biomedical High-Entropy Alloys Production Value by Region: 2021-2032
  7. 5.4.1 Global Biomedical High-Entropy Alloys Production Value by Region: 2021-2026
  8. 5.4.2 Global Biomedical High-Entropy Alloys Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Biomedical High-Entropy Alloys Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Biomedical High-Entropy Alloys Production and Value, YOY Growth
  11. 5.6.1 North America Biomedical High-Entropy Alloys Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Biomedical High-Entropy Alloys Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Biomedical High-Entropy Alloys Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Biomedical High-Entropy Alloys Production Value Estimates and Forecasts (2021-2032)
6 Global Biomedical High-Entropy Alloys Consumption by Region
  1. 6.1 Global Biomedical High-Entropy Alloys Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomedical High-Entropy Alloys Consumption by Region (2021-2032)
  3. 6.2.1 Global Biomedical High-Entropy Alloys Consumption by Region: 2021-2026
  4. 6.2.2 Global Biomedical High-Entropy Alloys Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biomedical High-Entropy Alloys Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biomedical High-Entropy Alloys Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Biomedical High-Entropy Alloys Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Biomedical High-Entropy Alloys Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Biomedical High-Entropy Alloys Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Biomedical High-Entropy Alloys Production by Type (2021-2032)
  2. 7.1.1 Global Biomedical High-Entropy Alloys Production by Type (2021-2032) & (Tons)
  3. 7.1.2 Global Biomedical High-Entropy Alloys Production Market Share by Type (2021-2032)
  4. 7.2 Global Biomedical High-Entropy Alloys Production Value by Type (2021-2032)
  5. 7.2.1 Global Biomedical High-Entropy Alloys Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Biomedical High-Entropy Alloys Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Biomedical High-Entropy Alloys Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Biomedical High-Entropy Alloys Production by Application (2021-2032)
  2. 8.1.1 Global Biomedical High-Entropy Alloys Production by Application (2021-2032) & (Tons)
  3. 8.1.2 Global Biomedical High-Entropy Alloys Production Market Share by Application (2021-2032)
  4. 8.2 Global Biomedical High-Entropy Alloys Production Value by Application (2021-2032)
  5. 8.2.1 Global Biomedical High-Entropy Alloys Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Biomedical High-Entropy Alloys Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Biomedical High-Entropy Alloys Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Biomedical High-Entropy Alloys Value Chain Analysis
  2. 9.1.1 Biomedical High-Entropy Alloys Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Biomedical High-Entropy Alloys Production Mode & Process
  5. 9.2 Biomedical High-Entropy Alloys Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Biomedical High-Entropy Alloys Distributors
  8. 9.2.3 Biomedical High-Entropy Alloys Customers
10 Global Biomedical High-Entropy Alloys Analyzing Market Dynamics
  1. 10.1 Biomedical High-Entropy Alloys Industry Trends
  2. 10.2 Biomedical High-Entropy Alloys Industry Drivers
  3. 10.3 Biomedical High-Entropy Alloys Industry Opportunities and Challenges
  4. 10.4 Biomedical High-Entropy Alloys Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research